Appointed in the midst of the Greek economic crisis, compounded by significant changes at the corporate Merck brand, Merck Greece’s MD, Konstantinos Kofinas, did not shy away from challenges. He speaks about his leadership approach, Merck’s key therapeutic areas in Greece, as well as industry collaboration in creating a sustainable healthcare environment.
Mr. Kofinas, you valiantly assumed the role of Managing Director in 2014, leading the company amidst a period when Merck was undergoing significant changes at the global level, exacerbated by the challenges brought on by some of the most difficult times of the Greek economic crisis. What was your leadership approach coming into the role?
"As Merck, we are fully aligned with SFEE objectives which encompass the rights of the whole industry as invoked by its name, the Pan-Hellenic Association of Pharmaceutical Companies."
